President Trump has been pursuing policies intended to entice drugmakers to bring manufacturing and jobs to the U.S. GSK’s announcement makes it the latest big pharma company to unveil a multi-billion dollar plan for new U.S. facilities. The post GSK Plans to Spend $30B on U.S. Manufacturing and R&D Infrastructure Over the Next 5 Years…
Inozyme Pharma’s main asset is in pivotal testing in children who have a rare enzyme deficiency that affects bones and blood vessels. BioMarin Pharmaceutical, already well established in enzyme replacement, said it will use its experience and infrastructure to grow the market for this product, potentially for several indications. The post BioMarin’s $270M Inozyme Acquisition…
May has seen a slew of executive hires, exits and layoffs across the healthcare industry. For instance, Abridge, Highmark Health and Merck named new executives. There were also layoffs at organizations including Innovaccer, Intermountain Health and Novartis. The post Healthcare Moves: A Monthly Summary of Hires, Exits and Layoffs appeared first on MedCity News.
The FDA will remove black box warnings on hormone replacement therapies after evidence showed the risks were overstated. The post FDA Will Remove Warnings for HRT Products Used for Menopause appeared first on MedCity News.
As we confront the sobering statistics and growing impact of colorectal cancer, it’s clear that more education about the various options for testing is needed to increase screening rates across the U.S. The post A Closer Look at FIT Tests – A Primer on the Various Options for Colorectal Cancer Screening appeared first on MedCity News.
Sabrina Chugani, Remo Health’s chief growth officer, speaks about partnering with ACOs and health plans to provide a care team that supports both patients and caregivers
Discrete choice experiments quantify respondent preferences over different alternative treatments due to their attributes. DCE assume individuals are rational and do not pick dominated options (i.e., where one option is weakly better than another option across all attributes and strictly better than the option across at least one attribute). However, Johnson et al. (2019) finds…
President Trump has prioritized mass deportation and detention of undocumented immigrations. This brief looks at recent trends in detention using Immigration and Customs Enforcement (ICE) data and health care risks and challenges facing those held in detention facilities.
The future of healthcare AI may depend less on algorithms and more on credibility. Presbyterian Healthcare Services is testing that theory with a clinician-led deployment strategy.
To fully capitalize on its potential, laboratories must ensure they understand how to use AI effectively. Without this understanding, there’s a risk of undermining the technology’s benefits and potentially harming the industry as a whole. The post Harnessing AI in Pathology: A Vital Tool That Requires Careful Ownership appeared first on MedCity News.